![\"\"](\"https:\/\/mira-lab.com\/wp-content\/uploads\/2022\/01\/Untitled-14.jpg\")
<\/p>\n<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
The kit is intended for the detection of protein C activity in human blood plasma to diagnose innate and acquired deficit of this anticoagulant.
\nPrinciple. Method of detection of protein C activity in blood plasma is based on the ability of activated protein C to hydrolyze peptide chromogen
\nsubstrate. Quantity of released dye pNA is in direct proportion to activity of protein C in plasma sample. Protein C of plasma is activated by
\nadding of purified extract of Agkistrodon contortrix contortrix toxin. Process has following scheme:
\nProtein C + activator (surplus) ==> Activated protein C
\nActivated protein C + peptide \u2013 pNA ==> peptide + pNA<\/p>\n
REACHROM PROTEIN C \u2013 TEST<\/strong> <\/p>\n <\/p>\n <\/p>\n PROREIN C Screening Test<\/strong> <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n ReaPrC\/FV Test<\/strong> <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n CONTROL PLASMA with normal and<\/strong> <\/p>\n <\/p>\n <\/p>\n <\/p>\n","protected":false},"excerpt":{"rendered":" The kit is intended for the detection of protein C activity in human blood plasma to diagnose innate and acquired deficit of this anticoagulant. Principle. Method of detection of protein C activity in blood plasma is based on the ability of activated protein C to hydrolyze peptide chromogen substrate. Quantity of released dye pNA is in direct proportion to activity of protein C in plasma sample. Protein C of plasma is activated by adding of purified extract of Agkistrodon contortrix contortrix toxin. Process has following scheme: Protein C + activator (surplus) ==> Activated protein C Activated protein C + peptide \u2013 pNA ==> peptide + pNA REACHROM PROTEIN C \u2013 TEST The kit of reagents for the determination protein C activity by photometric method Cat. # PFA-5 for 20-100 assays. Reagents: – concentrated buffer (2 mL) \u2013 1 vial; – protein C activator (5 mL), lyophilized \u2013 2 vials; – standard plasma (1 mL), lyophilized \u2013 1 vial; – chromogenic substrate (2 mL), lyophilized \u2013 2 vials PROREIN C Screening Test The kit of reagents for the determination of total activity of protein C system. Cat. # PFA-3-for 40-80 assays. The kit is intended for the detection of innate or acquired deficiency of protein C system and for the detection mutant factor V (Leiden), resistant to protein C, by clotting method. ReaPrC\/FV Test The kit of reagents for the determination of total activity of protein C system. Cat. # PFA-4-for 10-20 assays. New form of hereditary thrombophilia is characterized. In the base of this form factor V Leiden presents among patients. Main of this form is that factor V Leiden (mutant factor V of coagulation system) has resistance to the action of activated protein C, that leads to increase of internal and external coagulation ways and raises frequency of thrombosis: thrombosis of peripheral veins, myocardial infarction, thromboembolism of pulmonary artery, thrombosis of retina veins and others. CONTROL PLASMA with normal and abnormal level of anticoagulation system of protein C The kit of reagents for the determination of total activity of protein C system. Cat. # PFA-6\/7: normal level (1ml)-3 vials, abnormal level (1ml)-3 vials. Control plasma with normal level of anticoagulation system of protein C is used for control the detection of total activity of protein C system and for the detection of resistance of activated FVa to the action of activated protein C. It is used with the kits \u201cProtein C test\u201d and \u201cReaPrC\/FV test\u201d. <\/p>\n","protected":false},"featured_media":4399,"template":"","meta":{"nf_dc_page":""},"product_brand":[],"product_cat":[206],"product_tag":[],"class_list":["post-4398","product","type-product","status-publish","has-post-thumbnail","product_cat-renam","cms-has-post-thumbnail","first","instock","shipping-taxable","product-type-simple"],"_links":{"self":[{"href":"https:\/\/mira-lab.com\/new\/wp-json\/wp\/v2\/product\/4398","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mira-lab.com\/new\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/mira-lab.com\/new\/wp-json\/wp\/v2\/types\/product"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mira-lab.com\/new\/wp-json\/wp\/v2\/media\/4399"}],"wp:attachment":[{"href":"https:\/\/mira-lab.com\/new\/wp-json\/wp\/v2\/media?parent=4398"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/mira-lab.com\/new\/wp-json\/wp\/v2\/product_brand?post=4398"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/mira-lab.com\/new\/wp-json\/wp\/v2\/product_cat?post=4398"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/mira-lab.com\/new\/wp-json\/wp\/v2\/product_tag?post=4398"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nThe kit of reagents for the determination protein C activity by<\/strong>
\nphotometric method<\/strong>
\nCat. # PFA-5 for 20-100 assays.
\nReagents:
\n– concentrated buffer (2 mL) \u2013 1 vial;
\n– protein C activator (5 mL), lyophilized \u2013 2 vials;
\n– standard plasma (1 mL), lyophilized \u2013 1 vial;
\n– chromogenic substrate (2 mL), lyophilized \u2013 2 vials<\/p>\n
\nThe kit of reagents for the<\/strong>
\ndetermination of total activity of<\/strong>
\nprotein C system.<\/strong>
\nCat. # PFA-3-for 40-80 assays.
\nThe kit is intended for the detection of innate or acquired deficiency of
\nprotein C system and for the detection mutant factor V (Leiden), resistant to
\nprotein C, by clotting method.![\"\"](\"https:\/\/mira-lab.com\/wp-content\/uploads\/2022\/01\/Untitled-15.png\")
<\/p>\n
\nThe kit of reagents for the determination<\/strong>
\nof total activity of protein C system.<\/strong>
\nCat. # PFA-4-for 10-20 assays.
\nNew form of hereditary thrombophilia is characterized. In the base of this form factor V Leiden presents among patients.
\nMain of this form is that factor V Leiden
\n(mutant factor V of coagulation system) has resistance to the action of activated
\nprotein C, that leads to increase of internal and external coagulation ways and raises frequency of thrombosis: thrombosis of
\nperipheral veins, myocardial infarction, thromboembolism of pulmonary artery,
\nthrombosis of retina veins and others.<\/p>\n<\/p>\n
\nabnormal level of anticoagulation<\/strong>
\nsystem of protein C<\/strong>
\nThe kit of reagents for the determination of total activity of protein C system.
\nCat. # PFA-6\/7: normal level (1ml)-3 vials, abnormal level (1ml)-3 vials.
\nControl plasma with normal level of anticoagulation system of protein C is used for control the detection of total
\nactivity of protein C system and for
\nthe detection of resistance of activated FVa to the action of activated protein
\nC. It is used with the kits \u201cProtein C
\ntest\u201d and \u201cReaPrC\/FV test\u201d.<\/p>\n![\"\"](\"https:\/\/mira-lab.com\/wp-content\/uploads\/2022\/01\/Untitled-17.png\")
<\/p>\n